Brian K. Link
University of Iowa(US)University of Iowa Hospitals and Clinics(US)Iowa City Public Library(US)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Viral-associated cancers and disorders, Monoclonal and Polyclonal Antibodies Research, CNS Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.(1998)2,755 cited
- → Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes(2018)1,920 cited
- → Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study(2017)1,636 cited
- → Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing(2012)978 cited
- → Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study(2015)829 cited
- → Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment